Validation of analytical methods according to the new fda guidance
Download
1 / 5

Validation of Analytical Methods according to the New FDA Guidance - PowerPoint PPT Presentation


  • 83 Views
  • Uploaded on

FDA has released a new comprehensive guidance for validation of analytical methods. The guidance follows the modern integrated lifecycle approach with related new requirements for using quality-by-design components, risk assessment, design space and continuous improvement. The guidance will significantly change the way how FDA regulated methods will be developed, validated and used. Because of the novelty of some of the concepts the industry has difficulties to understand and implement the guidance. Attendees of this seminar will understand and learn how to implement the new guidance. \n

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Validation of Analytical Methods according to the New FDA Guidance' - GRCTS


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Validation of analytical methods according to the new fda guidance

Validation of Analytical Methods according to the New FDA Guidance

Speaker: Ludwig Huber| Date: 15th September 2016 2016 2016 | 10:00 AM PST | 01:00 PM EST

Contact Us : Email: [email protected] | Tel: +1-248-233-2049


Description

FDA has released a new comprehensive guidance for validation of analytical methods. The guidance follows the modern integrated lifecycle approach with related new requirements for using quality-by-design components, risk assessment, design space and continuous improvement. The guidance will significantly change the way how FDA regulated methods will be developed, validated and used. Because of the novelty of some of the concepts the industry has difficulties to understand and implement the guidance. Attendees of this seminar will understand and learn how to implement the new guidance.

Description:


Areas covered in the session

  • Key differences to the existing of analytical methods. The guidance follows the modern integrated lifecycle approach with related new requirements for using quality-by-design components, risk assessment, design space and continuous improvement. The guidance will significantly change the way how FDA regulated methods will be developed, validated and used. Because of the novelty of some of the concepts the industry has difficulties to understand and implement the guidance. Attendees of this seminar will understand and learn how to implement the new guidance.guidance

  • Scope and content of the guidance

  • Going through validation parameters, tests, and acceptance criteria

  • Comparison with ICH Q2

  • How to apply the lifecycle management for analytical procedures

  • When and how to periodic review and revalidate methods

  • Analytical method comparability studies for alternative methods

  • Recommendations analytical method transfer studies

  • Development experiments that should be conducted under GMP conditions

  • Application of QbD components: design space, multivariate experiments, risk assessment

Areas Covered in the Session:


Who will benefit

  • QC of analytical methods. The guidance follows the modern integrated lifecycle approach with related new requirements for using quality-by-design components, risk assessment, design space and continuous improvement. The guidance will significantly change the way how FDA regulated methods will be developed, validated and used. Because of the novelty of some of the concepts the industry has difficulties to understand and implement the guidance. Attendees of this seminar will understand and learn how to implement the new guidance.Managers

  • QA Managers and Personnel

  • IT Administrators

  • Regulatory Affairs

  • Training Departments

  • Validation Groups

  • Documentation Department

  • Consultants

Who will benefit:


Instructor profile

Ludwig Huber of analytical methods. The guidance follows the modern integrated lifecycle approach with related new requirements for using quality-by-design components, risk assessment, design space and continuous improvement. The guidance will significantly change the way how FDA regulated methods will be developed, validated and used. Because of the novelty of some of the concepts the industry has difficulties to understand and implement the guidance. Attendees of this seminar will understand and learn how to implement the new guidance., Ph.D., is the director of Lab compliance and  editor of w.labcompliance.com, the global online resource for validation and compliance. He is the author of the books "Validation and Qualification in Analytical Laboratories" and "Validation of Computerized Analytical and Networked Systems". He has given multiple presentations mainly on GLP/GMP, 21 CFR Part 11, and Validation around the world. This included seminars, workshops and presentations for the US FDA, China CFDA, , ISPE, Japan PDA, PIC/S and several other national health care agencies. 

Instructor Profile :


ad